The emergence of a global health crisis in early 2020 represented an unprecedented challenge for the modern medical and scientific community. The rapid spread of a novel virus tested the limits of existing healthcare infrastructure, scientific knowledge, and international coordination. In response, pharmaceutical companies, research institutions, and governments mobilized at a pace previously unseen in modern history. The development, testing, regulatory… CONTINUE READING…
Categories: News
